SYMBIO GENERRICS INDIA PRIVATE LIMITED

Active    As on: 14 April, 2024    Update Info    Print    Share

OVERVIEW - SYMBIO GENERRICS INDIA PRIVATE LIMITED

Symbio Generrics India Private Limited is an unlisted private company incorporated on 30 May, 2011. It is classified as a private limited company and is located in Bangalore, Karnataka. It's authorized share capital is INR 3.10 cr and the total paid-up capital is INR 3.01 cr.

Symbio Generrics India's operating revenues range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by -49.36 % over the previous year. At the same time, it's book networth has increased by 62.24 %. Other performance and liquidity ratios are available here.

Description: The company is engaged in manufacturing of pharmaceutical product such as tablets, capsules, syrups, injectable, ointments, eye drop, protein powder etc.

Products & Services: Heparin Sodium Injection, Enoxaparin Sodium InjectionTablets, Capsules, Syrups, Injectable, Ointments, Eye Drop, Protein Powder etc.
Category: Manufacturer

The current status of Symbio Generrics India Private Limited is - Active.

The last reported AGM (Annual General Meeting) of Symbio Generrics India Private Limited, per our records, was held on 30 September, 2023.

Symbio Generrics India Private Limited has five directors - Ajay Mittal, Sharma Natraj Kannan, and others.

The Corporate Identification Number (CIN) of Symbio Generrics India Private Limited is U74990KA2011PTC184231. The registered office of Symbio Generrics India Private Limited is at Symbio House, No-1215, 24th Main, 11th Cross, HSR Layout 1st Sector, HSR Layout, Bangalore South, Bangalore, Karnataka.

  • COMPANY FINANCIALS
  • INR 349
    Company360 is an interactive dashboard that provides more than 3 years company’s financials, ratios, charts, network and features like lists, comparator, financial alerts, pdf reports, and excel downloads.
    Learn More
  • INR 349
    All financials and shareholder returns available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 249
    Latest Balance Sheet, Profit and Loss# and shareholder return available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 799
    An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
    Delivery time: 1 working day (Mon-Fri).
    View a Sample Report
  • INR 2999
    A pdf report that includes standalone and consolidated financials, risk analysis, cashflows, capital infusion details, litigation, credit ratings, group structure, GST details, Competition analysis and more.
    Delivery time: 2 working days (Mon-Fri).
    View a Sample Report
  • # Wherever available
    * Prices are exclusive of taxes.
    ** Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
    *** Working hours: 9am-6pm (Mon-Fri)

Company360 plans

360lite-screenshot

Know more about your vendors, clients and competitors.


Financials, scores, ratios, excels, reports and more.

@ INR 9000/quarter

take free trial

Join our newsletter

For business and industry related insights, twice in a month. No spam.

Check out our latest blogs:

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Demystifying Supply Chain Challenges: A Practical Guide

In the intricate world of supply chain management, companies face a......

read more

REGISTERED DETAILS - SYMBIO GENERRICS INDIA PRIVATE LIMITED


CIN

U74990KA2011PTC184231

Incorporation Date / Age

30 May, 2011 / 13 yrs

Last Reported AGM Date

30 September, 2023


Authorized Capital

INR 310.0 Lacs

Paidup Capital

INR 300.7803 Lacs

industry*

Business Services


type

Unlisted Private Company

category

Company limited by Shares

subcategory

Non-govt company


Email Address

Login for email address. This is to prevent spam.

Website

https://symbiogenerics.com/. (Incorrect website?)

Registered Address

Symbio House, No-1215, 24th Main, 11th Cross, HSR Layout 1st
Sector, HSR Layout
Bangalore South
Bangalore - 560102
Karnataka - India


How to download SYMBIO GENERRICS INDIA PRIVATE LIMITED report

A Company report by Tofler is an easy-to-read PDF report that includes company's financial information, ratio analysis, management, group structure, shareholding pattern and more. Such reports can be bought from company pages at Tofler (Sample) or can be downloaded from Company360. Here is the video showing how a report downloaded from Company360 looks like.

SYMBIO GENERRICS INDIA PRIVATE LIMITED - Registration Details
CINU74990KA2011PTC184231
Incorporation Date / Age30 May, 2011 / 13 yrs
Last Reported AGM Date30 September, 2023
Authorized CapitalINR 310.0 Lacs
Paidup CapitalINR 300.7803 Lacs
industry*Business Services
typeUnlisted Private Company
categoryCompany limited by Shares
subcategoryNon-govt company
Email Address
Websitehttps://symbiogenerics.com/
Registered AddressSymbio House, No-1215, 24th Main, 11th Cross, HSR Layout 1st Sector, HSR Layout Bangalore South Bangalore - 560102 Karnataka - India

FINANCIAL HIGHLIGHTS - SYMBIO GENERRICS INDIA PRIVATE LIMITED

Provided here are the financial indicators for financial year ending on 31 March, 2023. Actual numbers and updated financial data are included in purchased financial report.
View Sample Report.
Operating Revenue INR 100 cr - 500 cr
EBITDA -49.36 %
Networth 62.24 %
Debt/Equity Ratio 0.39
Return on Equity 7.45 %

* Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.

How to get financial reports of SYMBIO GENERRICS INDIA PRIVATE LIMITED

Tofler Company360 provides access to any Indian company's financial documents, charts, ratio analysis and more. It lets you compare financials of several companies and study performance trends. These financials can also be downloaded in excel format. Here is the video showing how you can study the financials of an Indian company on the Company360 platform.

Directors - SYMBIO GENERRICS INDIA PRIVATE LIMITED

The company has 5 directors and 1 reported key management personnel.


The longest serving director currently on board is Salim Sadiq Shaikh who was appointed on 30 May, 2011. Salim Sadiq Shaikh has been on the board for more than 12 years. The most recently appointed director is Sharma Natraj Kannan, who was appointed on 19 September, 2022.


Salim Sadiq Shaikh has the largest number of other directorships with a seat at a total of 10 companies. In total, the company is connected to 25 other companies through its directors.


NAME DESIGNATION APPOINTMENT DATE
AJAY MITTAL Director 30 March, 2022 Other directorships - SAPIANTSAGES PARTNERS LLP,  ALTIUS CAPITAL INDIA PRIVATE LIMITED,  LAQSHYA HYDERABAD AIRPORT MEDIA PRIVATE LIMITED,  FRESHTOHOME FOODS PRIVATE LIMITED,  LAQSHYA MEDIA LIMITED, 
SHARMA NATRAJ KANNAN Director 19 September, 2022 Other directorships - QUANTUM REMEDIES PRIVATE LIMITED,  GRANDIX LABORATORIES LIMITED,  SEQUENT SCIENTIFIC LIMITED,  RENEW AKSHAY URJA LIMITED, 
DEEPAK KOMAREGOWDA Director 30 March, 2022 Other directorships - SAPIANTSAGES PARTNERS LLP,  SKANRAY HEALTHCARE PRIVATE LIMITED,  INURTURE GALILEO INDIA PRIVATE LIMITED,  SKANRAY TECHNOLOGIES LIMITED,  NAARI PHARMA PRIVATE LIMITED,  I-NURTURE EDUCATION SOLUTIONS PRIVATE LIMITED,  INURTURE 360 CAREERS PRIVATE LIMITED,  GLOBAL DELIGHT TECHNOLOGIES PRIVATE LIMITED, 
SALIM SADIQ SHAIKH Director 30 May, 2011 Other directorships - COPERNICIUM PHARMACEUTICALS PRIVATE LIMITED,  ACTINIC PHARMACEUTICALS PRIVATE LIMITED,  PLAINVIEW PHARMACEUTICALS PRIVATE LIMITED,  BLUMEN BIOVITALS HEALTHKARE PRIVATE LIMITED,  SYMBIO NATURAL PRODUCTS PRIVATE LIMITED,  LAUNCHMYDRUG TECHNOLOGIES PRIVATE LIMITED,  STRIDER LIFESCIENCES PRIVATE LIMITED,  VPL CHEMICALS PRIVATE LIMITED,  WISERISE VENTURES PRIVATE LIMITED, 
AKASH SURESH PURANIK KMP 30 March, 2022 No other directorships
AKASH SURESH PURANIK Director 30 March, 2022 Other directorships - COPERNICIUM PHARMACEUTICALS PRIVATE LIMITED,  SYMBIO NATURAL PRODUCTS PRIVATE LIMITED,  VPL CHEMICALS PRIVATE LIMITED, 
NAME DESIGNATION APPOINTMENT DATE
AJAY MITTAL Director 30 March, 2022 View other directorships
SHARMA NATRAJ KANNAN Director 19 September, 2022 View other directorships
DEEPAK KOMAREGOWDA Director 30 March, 2022 View other directorships
SALIM SADIQ SHAIKH Director 30 May, 2011 View other directorships
AKASH SURESH PURANIK KMP 30 March, 2022 No other directorships
AKASH SURESH PURANIK Director 30 March, 2022 View other directorships
30 May, 2011
30 March, 2022

AJAY MITTAL

Director

30 March, 2022
30 March, 2022

AKASH SURESH PURANIK

KMP

30 March, 2022
19 September, 2022

Bank-wise Biggest Charges on Assets

See more...

Previous Names

No previous names were found for this company.

Previous CINs

U74990TN2011PTC080853

SIMILAR COMPANIES

NAME INCORPORATION YEAR STATE PAID UP CAPITAL
GANESH FILMS INDIA LIMITED It was formed in year 2018 in Maharashtra . The company currently has a paid up capital of INR 3.01 cr.
2018 Maharashtra 3.01 cr Buy financial reports
FELIX CAPITAL SERVICES PRIVATE LIMITED It was formed in year 2016 in West Bengal . The company currently has a paid up capital of INR 3.01 cr.
2016 West Bengal 3.01 cr Buy financial reports
BHARATH ENERGY PRIVATE LIMITED It was formed in year 2008 in Tamil Nadu . The company currently has a paid up capital of INR 3.01 cr.
2008 Tamil Nadu 3.01 cr Buy financial reports
PAWAN LIQUORS COMPANY LIMITED It was formed in year 2000 in Chandigarh . The company currently has a paid up capital of INR 3.01 cr.
2000 Chandigarh 3.01 cr Buy financial reports
APJ PACKAGING PRIVATE LIMITED It was formed in year 2001 in Delhi . The company currently has a paid up capital of INR 3.01 cr.
2001 Delhi 3.01 cr Buy financial reports
MURARI ENTERPRISES PRIVATE LIMITED It was formed in year 2008 in Uttar Pradesh . The company currently has a paid up capital of INR 3.01 cr.
2008 Uttar Pradesh 3.01 cr Buy financial reports
TANGI FACILITY SOLUTIONS PRIVATE LIMITED It was formed in year 2014 in Tamil Nadu . The company currently has a paid up capital of INR 3.01 cr.
2014 Tamil Nadu 3.01 cr Buy financial reports
TANGERINE DESIGN PRIVATE LIMITED It was formed in year 2013 in Haryana . The company currently has a paid up capital of INR 3.01 cr.
2013 Haryana 3.01 cr Buy financial reports
PLAYIZZON TECHNOLOGIES PRIVATE LIMITED It was formed in year 2015 in Maharashtra . The company currently has a paid up capital of INR 3.01 cr.
2015 Maharashtra 3.01 cr Buy financial reports
HIND DEFENCE EQUIPMENT PRIVATE LIMITED It was formed in year 2016 in Maharashtra . The company currently has a paid up capital of INR 3.01 cr.
2016 Maharashtra 3.01 cr Buy financial reports

SUBSIDIARY COMPANIES

NAME STATE INCORPORATION YEAR PAID UP CAPITAL
Karnataka 1999 49.90 lac
Karnataka 2013 4.21 lac

Company Network - SYMBIO GENERRICS INDIA PRIVATE LIMITED

Company Network • Tofler Business Research Platform
How to use company network of SYMBIO GENERRICS INDIA PRIVATE LIMITED

Tofler Company network is a powerful feature that allows you to explore and discover common directorships between companies. It helps you find out other directorships of an Indian director and where else he has business interests. The feature is available for unlimited use in Company360 platform. Here is the video showing how you can explore company networks to discover hidden relationships between companies.

FAQ - SYMBIO GENERRICS INDIA PRIVATE LIMITED

  • What is the Incorporation date of SYMBIO GENERRICS INDIA PRIVATE LIMITED?

    The Incorporation Date of SYMBIO GENERRICS INDIA PRIVATE LIMITED is 30 May, 2011.

  • What is the operating revenue of SYMBIO GENERRICS INDIA PRIVATE LIMITED?

    The operating revenue of SYMBIO GENERRICS INDIA PRIVATE LIMITED is in the range of INR 100 cr - 500 cr for the financial year ending on 31 March, 2023.

  • What is the change in EBITDA of SYMBIO GENERRICS INDIA PRIVATE LIMITED since last year?

    The EBITDA of SYMBIO GENERRICS INDIA PRIVATE LIMITED has decreased by -49.36 % over the previous year. At the same time, it's book networth has increased by 62.24 % for the financial year ending 31 March, 2023.

  • What is the business of SYMBIO GENERRICS INDIA PRIVATE LIMITED?

    The company is engaged in manufacturing of pharmaceutical product such as tablets, capsules, syrups, injectable, ointments, eye drop, protein powder etc..

  • Which Products and Services are provided by SYMBIO GENERRICS INDIA PRIVATE LIMITED?

    The products and services offered by SYMBIO GENERRICS INDIA PRIVATE LIMITED are Heparin Sodium Injection, Enoxaparin Sodium InjectionTablets, Capsules, Syrups, Injectable, Ointments, Eye Drop, Protein Powder etc..

  • Who are the directors of SYMBIO GENERRICS INDIA PRIVATE LIMITED?

    Symbio Generrics India Private Limited has five directors - Ajay Mittal, Sharma Natraj Kannan, and others.

  • COMPANY FINANCIALS
  • INR 349
    Company360 is an interactive dashboard that provides more than 3 years company’s financials, ratios, charts, network and features like lists, comparator, financial alerts, pdf reports, and excel downloads.
    Learn More
  • INR 349
    All financials and shareholder returns available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 249
    Latest Balance Sheet, Profit and Loss# and shareholder return available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 799
    An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
    Delivery time: 1 working day (Mon-Fri).
    View a Sample Report
  • INR 2999
    A pdf report that includes standalone and consolidated financials, risk analysis, cashflows, capital infusion details, litigation, credit ratings, group structure, GST details, Competition analysis and more.
    Delivery time: 2 working days (Mon-Fri).
    View a Sample Report
  • # Wherever available
    * Prices are exclusive of taxes.
    ** Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
    *** Working hours: 9am-6pm (Mon-Fri)

Company360 plans

360lite-screenshot

Know more about your vendors, clients and competitors.


Financials, scores, ratios, excels, reports and more.

@ INR 9000/quarter

take free trial

Join our newsletter

For business and industry related insights, twice in a month. No spam.

Check out our latest blogs:

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Demystifying Supply Chain Challenges: A Practical Guide

In the intricate world of supply chain management, companies face a......

read more



Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to their respective owners. Read More